Aligos Therapeutics Inc (ALGS)

16.27 -0.03  -0.18% NASDAQ Nov 26, 16:00 USD

Aligos Therapeutics Free Cash Flow (Quarterly):

-25.46M for Sept. 30, 2021
View 4,000+ financial data types
View Full Chart

Free Cash Flow (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Free Cash Flow (Quarterly) Data

View and export this data going back to 2020. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 -25.46M
June 30, 2021 -23.17M
March 31, 2021 -30.10M
Dec. 31, 2020 -19.74M
Sept. 30, 2020 -16.91M
June 30, 2020 -18.26M
March 31, 2020 -21.41M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Benchmarks

CEL-SCI Corp -7.20M
AIM ImmunoTech Inc -3.544M
NovaBay Pharmaceuticals Inc -1.485M

Free Cash Flow (Quarterly) Range, Past 5 Years

Minimum -30.10M Mar 2021
Maximum -16.91M Sep 2020
Average -22.15M





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.